Ezetimibe and Simvastatin
Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects
7
METHOD DEVELOPMENT AND VALIDATION OF EZETIMIBE AND SIMVASTATIN IN PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC METHOD
9
Development of RP-HPLC method for simultaneous estimation of ezetimibe and simvastatin in tablet formulation
7
Ezetimibe and simvastatin for the prevention of cardiovascular events in predialysis chronic kidney disease patients: a review
5
DEVELOPMENT AND VALIDATION OF RP HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND SIMVASTATIN IN BULK AND COMBINED TABLET DOSAGE FORM
10
Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination
8
Stability indicating RP-HPLC method for simultaneous determination of simvastatin and ezetimibe from tablet dosage form
7
Simultaneous spectroscopic estimation of ezetimibe and simvastatin in tablet dosage forms
5
Efficacy of Ezetimibe/Simvastatin (10/10 mg) Versus High Dose Statin in Dyslipidemia Patients: A Meta-analysis of Randomized Controlled Trials
13
Ezetimibe + simvastatin versus doubling the dose of simvastatin in high cardiovascular risk diabetics: a multicenter, randomized trial (the LEAD study)
8
Simultaneous Estimation of Simvastatin and Ezetimibe by Rp-Hplc in Pure and Pharmaceutical Dosage Form
6
Consistency of effect of ezetimibe/simvastatin compared with intensified lipid-lowering treatment strategies in obese and non-obese diabetic subjects
10
RP-HPLC Method Development and Validation for the Simultaneous estimation of Simvastatin and Ezetimibe in Tablet Dosage Form
9
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
9
Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk
12
Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
8
Ezetimibe/Simvastatin 10/20 mg versus Rosuvastatin 10 mg in high-risk hypercholesterolemic patients stratified by prior statin treatment potency
8
Simultaneous derivative and multicomponent spectrophotometric determination of Simvastatin and Ezetimibe in tablets
5
RP-HPLC method for simultaneous estimation of simvastatin and ezetimibe in tablet dosage forms
13
SIMPLE BIOANALYTICAL QUANTIFICATION METHOD FOR SIMULTANEOUS ESTIMATION OF SIMVASTATIN AND EZETIMIBE IN HUMAN PLASMA BY REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY TECHNIQUE
6